What is Taro Pharmaceutical Industries Operating Cash Flow per Share?
Taro Pharmaceutical Industries's operating cash flow per share for the
three
months ended in Dec. 2023 was $0.82.
Taro Pharmaceutical Industries's operating cash flow per share for the trailing twelve months (TTM) ended in Dec. 2023 was $3.80.
During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Taro Pharmaceutical Industries was 771.80% per year.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -50.70% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.
The historical rank and industry rank for Taro Pharmaceutical Industries's Operating Cash Flow per Share or its related term are showing as below:
TARO'
s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -50.7 Med: 31.35 Max: 270.9
Current: -50.7
During the past 13 years, Taro Pharmaceutical Industries's highest 3-Year average Operating Cash Flow per Share Growth Rate was 270.90% per year. The lowest was -50.70% per year. And the median was 31.35% per year.
TARO's 3-Year OCF Growth Rate is ranked worse than 95.42% of 807
companies
in the Drug Manufacturers industry
Industry Median: 8.2
vs TARO: -50.70
Taro Pharmaceutical Industries Operating Cash Flow per Share Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Taro Pharmaceutical Industries Operating Cash Flow per Share Chart
Competitive Comparison of Taro Pharmaceutical Industries's Operating Cash Flow per Share
For the Drug Manufacturers - Specialty & Generic subindustry, Taro Pharmaceutical Industries's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Taro Pharmaceutical Industries's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Taro Pharmaceutical Industries's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Taro Pharmaceutical Industries's Price-to-Operating-Cash-Flow falls into.
Taro Pharmaceutical Industries Operating Cash Flow per Share Calculation
Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.
Taro Pharmaceutical Industries's Operating Cash Flow per Share for the fiscal year that ended in Mar. 2023 is calculated as
Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $3.80
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Taro Pharmaceutical Industries Operating Cash Flow per Share Related Terms
Thank you for viewing the detailed overview of Taro Pharmaceutical Industries's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Taro Pharmaceutical Industries (Taro Pharmaceutical Industries) Business Description
Taro Pharmaceutical Industries Ltd produces, researches, develops, and markets pharmaceutical products. Its primary focus includes semi-solid formulations, such as creams and ointments, and other dosage forms such as liquids, capsules, and tablets. The company is engaged in the dermatological and topical, cardiovascular, neuropsychiatric, and anti-inflammatory therapeutic categories. Geographically, it derives a majority of its revenue from the United States and also has a presence in Canada, Israel, and Other Countries.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TARO has been successfully added to your 